The FDA approved an updated warning label for the birth control patch Ortho Evra on January 18, 2008. The results of a study showed that patch users were at higher risk of developing blood clots, known as venous thromboembolism, that could lead to fatal injury.

Women using Ortho Evra, which is manufactured by Johnson and Johnson, were at a higher risk of clots than women who use birth control pills. Women studied included those between the ages of 15 and 44. Health care researchers recommend that women who want to use the patch discuss the risks and the benefits with their doctors.
 
The Ortho Evra patch was also revised in September 2006 to warn women of the same risks. The patch releases an estrogen and a progestin hormone into the skin once the patch is applied. The hormones then travel into the bloodstream, and at that point women are exposed to 60 percent more estrogen than they are if they use birth control pills. These increased levels of estrogen can cause side effects including blood clots.
 

For information and resources about Diabetes & Diabetics, visit DiabeticConnect.com, the fastest growing online Diabetes Community.

The Healthy Human is a Health Supplies and services directory, medical supplies, health, nutrition, beauty, nutritional supplements, anything related to the human body.

Mental Health Abuse – Exposing the crimes of mental health practitioners.